Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (71-80 of 326) with videos related to

Pageof 33
Sort By:
Clinical Therapeutics|July 22, 2008
Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot studyValerio Nobili, Melania Manco, Paolo Ciampalini, et al.
Hepatology (Baltimore, Md.)|June 28, 2005
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver diseaseNicola Villanova, Simona Moscatiello, Stefano Ramilli, et al.
International Journal of Molecular Sciences|April 5, 2016
Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat LoadRoberto Gambino, Elisabetta Bugianesi, Chiara Rosso, et al.
Journal of the American College of Nutrition|June 24, 2011
Insulin dynamics of breast- or formula-fed overweight and obese childrenMelania Manco, Arianna Alterio, Elisabetta Bugianesi, et al.
Nutrients|December 11, 2022
Role of Circadian Clock on the Pathogenesis and Lifestyle Management in Non-Alcoholic Fatty Liver DiseaseNuria Perez-Diaz-Del-Campo, Gabriele Castelnuovo, Gian Paolo Caviglia, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosisElisabetta Bugianesi, Gulio Marchesini, Elena Gentilcore, et al.
Nutrients|July 13, 2024
A Healthful Plant-Based Diet as an Alternative Dietary Approach in the Management of Metabolic Dysfunction-Associated Steatotic Liver DiseaseGabriele Castelnuovo, Nuria Perez-Diaz-Del-Campo, Chiara Rosso, et al.
Pragmatic and Observational Research|October 15, 2024
Non-Alcoholic Steatohepatitis Patient Characterization and Real-World Management Approaches in ItalyElisabetta Bugianesi, Luca Miele, Giovanna Donnarumma, et al.
Journal of Hepatology|October 12, 2010
Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitisSilvia Gaia, Silvia Carenzi, Angela L Barilli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 7, 2014
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver diseaseSalvatore Petta, Ester Vanni, Elisabetta Bugianesi, et al.
Pageof 33

Showing results (71-80 of 326) with videos related to

Sort By:
Pageof 33
Clinical Therapeutics|July 22, 2008
Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot studyValerio Nobili, Melania Manco, Paolo Ciampalini, et al.
Hepatology (Baltimore, Md.)|June 28, 2005
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver diseaseNicola Villanova, Simona Moscatiello, Stefano Ramilli, et al.
International Journal of Molecular Sciences|April 5, 2016
Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat LoadRoberto Gambino, Elisabetta Bugianesi, Chiara Rosso, et al.
Journal of the American College of Nutrition|June 24, 2011
Insulin dynamics of breast- or formula-fed overweight and obese childrenMelania Manco, Arianna Alterio, Elisabetta Bugianesi, et al.
Nutrients|December 11, 2022
Role of Circadian Clock on the Pathogenesis and Lifestyle Management in Non-Alcoholic Fatty Liver DiseaseNuria Perez-Diaz-Del-Campo, Gabriele Castelnuovo, Gian Paolo Caviglia, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosisElisabetta Bugianesi, Gulio Marchesini, Elena Gentilcore, et al.
Nutrients|July 13, 2024
A Healthful Plant-Based Diet as an Alternative Dietary Approach in the Management of Metabolic Dysfunction-Associated Steatotic Liver DiseaseGabriele Castelnuovo, Nuria Perez-Diaz-Del-Campo, Chiara Rosso, et al.
Pragmatic and Observational Research|October 15, 2024
Non-Alcoholic Steatohepatitis Patient Characterization and Real-World Management Approaches in ItalyElisabetta Bugianesi, Luca Miele, Giovanna Donnarumma, et al.
Journal of Hepatology|October 12, 2010
Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitisSilvia Gaia, Silvia Carenzi, Angela L Barilli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 7, 2014
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver diseaseSalvatore Petta, Ester Vanni, Elisabetta Bugianesi, et al.
Pageof 33